Announcement on Progress in Sale of Repurchased Shares
Filed with SSE · · 4 pages · Chinese
Summary by 6ix AI
Shanghai Yizhong Pharmaceutical Co. Ltd. has announced progress regarding the sale of repurchased shares. The company repurchased shares to maintain value and shareholder rights, with plans to sell these shares through a centralized bidding process. As of the end of May, the company has sold a portion of the repurchased shares, with details on the number and price range provided. The proceeds from the sale will be used to support the company's working capital and ongoing research projects. The announcement also includes risk warnings related to the sale plan and compliance with regulatory requirements.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shanghai Yizhong Pharmaceutical Co. Ltd. on 6ix
Earlier from Shanghai Yizhong Pharmaceutical
- Announcement on Election of Employee Director
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Resolutions of the 16th Meeting of the 2nd Board of Directors
- Announcement on Renewing Engagement of Accounting Firm
- Indicative Announcement on Changes in Shareholder Equity Reaching Integer Multiple of 1%
Later from Shanghai Yizhong Pharmaceutical
- Announcement on Result of Shareholding Reduction by Shareholders
- Announcement on Voluntary Disclosure on the Acceptance of the Clinical Trial Application for the Investigational New Drug YXC-002
- Announcement on Early Termination of Current Plan for Sale of Repurchased Shares and Results of the Share Sale
- Announcement on the Proposal by Actual Controller and Chairman to Repurchase the Shares
- Announcement on Resolutions of the 3rd Meeting of the 3rd Board of Directors
Follow Shanghai Yizhong Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Yizhong Pharmaceutical